Literature DB >> 19489657

Acute urticaria and angioedema: diagnostic and treatment considerations.

Evangelo Frigas1, Miguel A Park.   

Abstract

Urticaria is defined as wheals consisting of three features: (i) central swelling of various sizes, with or without surrounding erythema; (ii) pruritus or occasional burning sensations; and (iii) the skin returning to normal appearance, usually within 1-24 hours. Angioedema is defined as: (i) abrupt swelling of the lower dermis and subcutis; (ii) occasional pain instead of pruritus; (iii) commonly involving the mucous membranes; and (iv) skin returning to normal appearance, usually within 72 hours. Acute urticaria and angioedema is defined by its duration (<6 weeks) compared with chronic urticaria and angioedema. The most common causes are infections, medications, and foods. The best tools in the evaluation of these patients are a comprehensive history and physical examination. There are a variety of skin conditions that may mimic acute urticaria and angioedema and the various reaction patterns associated with different drugs. Oral antihistamines are first-line treatment. In the event of a life-threatening reaction involving urticaria with angioedema, epinephrine may be needed to stabilize the patient. This review focuses on the value of a comprehensive clinical evaluation at the onset of symptoms. It underscores the importance of coordination of care among physicians, and the development of an action plan for evidence-based investigations, diagnosis, and therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19489657     DOI: 10.2165/00128071-200910040-00004

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  7 in total

Review 1.  Current and future therapies for the treatment of histamine-induced angioedema.

Authors:  Christine James; Jonathan A Bernstein
Journal:  Expert Opin Pharmacother       Date:  2017-01-25       Impact factor: 3.889

2.  Comparative Efficacy and Safety of Ebastine 20 mg, Ebastine 10 mg and Levocetirizine 5 mg in Acute Urticaria.

Authors:  Vippan Goyal; Anu Gupta; Onam Gupta; Dhruvendra Lal; Manharan Gill
Journal:  J Clin Diagn Res       Date:  2017-03-01

3.  Efficacy and safety of Xiaofeng powder (xiao feng san) in treating urticaria: A protocol for a systematic review and meta-analysis of randomized controlled trials.

Authors:  Guoming Chen; Jinlong Zhao; Tengyu Chen; Zhaoping Zhang; Chuyao Huang; Zhirui Xu; Hua Xu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

4.  Serum amyloid A levels in acute and chronic urticaria.

Authors:  Wei Lu; Baobing Chen; Chunfeng Wang; Xiaohong Yang; Changyu Zhou
Journal:  An Bras Dermatol       Date:  2019-10-17       Impact factor: 1.896

5.  Allergic reaction to anisakis-contaminated fish after the first administration of BNT162b2 mRNA vaccine: a case report.

Authors:  Fumiue Harada; Kana Yamamoto; Tomoki Matsuda; Chika Yamamoto; Yuta Tani; Mutsuko Ohnishi; Morihito Takita; Tetsuya Tanimoto; Masahiro Kami; Ryusaburo Shineha
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-08-11

6.  Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema.

Authors:  Jonathan A Bernstein; Joseph Moellman
Journal:  Int J Emerg Med       Date:  2012-11-06

Review 7.  Guideline of Chronic Urticaria Beyond.

Authors:  Lauren M Fine; Jonathan A Bernstein
Journal:  Allergy Asthma Immunol Res       Date:  2016-09       Impact factor: 5.764

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.